Viewing Study NCT04217135


Ignite Creation Date: 2025-12-24 @ 10:37 PM
Ignite Modification Date: 2025-12-31 @ 1:41 PM
Study NCT ID: NCT04217135
Status: UNKNOWN
Last Update Posted: 2022-01-06
First Post: 2019-12-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral Regurgitation
Sponsor: Kaohsiung Veterans General Hospital.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module